PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.\', \'Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.\', \'Bone Marrow Transplantation Unit, Hacettepe University Cancer Institute, Ankara, Turkey.\', \'Immuno-Oncology Program and COVID-19 Task Force, Ares Pharmaceuticals, St. Paul, MN 55110, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/oncolo/oyac032
?:doi
?:hasPublicationType
?:journal
  • The oncologist
is ?:pmid of
?:pmid
?:pmid
  • 35274729
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35274729>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35274729>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all